Hereditary Non-polyposis Colon Cancer Type 2: Disease Bioinformatics
Colorectal cancer, commonly referred to as colon cancer, originates in the colon (large intestine) or rectum, typically as adenomatous polyps. It is unknown what causes colorectal cancer yet familial adenomatous polposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) are thought to increase risk of developing colon cancer. Hereditary non-polyposis colon cancer type II (also known as type B) is frequently referred to as Lynch Syndrome. Individuals with HNPCC type B commonly report diagnosis early in life as well as an influx of diagnoses of related cancers such as gastric, ovarian, breast, and endometrial. Additionally, increasing age, inflammatory intestinal conditions, nationality, low fiber and high fat diet, diabetes, smoking, alcohol, obesity, and a sedentary lifestyle can contribute to colon cancer's onset. Treatments for colon cancer include surgery, chemotherapy, radiation therapy, and targeted drug therapy.
Hereditary Non-polyposis Colon Cancer Type 2 Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Hereditary Non-polyposis Colon Cancer Type 2 below!
For more information on how to use Laverne, please read the How to Guide.
We have 791 products for the study of Hereditary Non-polyposis Colon Cancer Type 2 that can be applied to Western Blot, Flow Cytometry, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.